The Taylor Family Department of Neurosurgery at WashU Medicine is recognizing Brain Tumor Awareness Month by highlighting a new publication in Neuro-Oncology focused on future directions in glioblastoma research.
Titled “Recent progress and future directions to advance glioblastoma research: a consensus perspective from the 2024 Christopher Davidson Forum,” examines key advances, ongoing challenges, and future directions in glioblastoma (GBM) research—one of the most complex and difficult-to-treat brain tumors. The Christopher Davidson Forum is a biennial meeting hosted at WashU Medicine that brings together more than 130 leading neuro-oncology experts from around the world.
The publication underscores the complexity of glioblastoma biology, the challenges of developing effective immunotherapies, and the need to advance emerging technologies to improve treatment. It also emphasizes the importance of continued multidisciplinary collaboration to accelerate progress and bring new therapies to patients.
Residents, research faculty, and clinical faculty from the Taylor Family Department of Neurosurgery contributed to this work alongside Brain Tumor Center faculty and staff from departments across WashU Medicine, reflecting a shared commitment to advancing discovery and improving outcomes for patients with brain tumors.